Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Ali Salanti(University of Copenhagen), Mads Daugaard(University of British Columbia), Mette Ø. Agerbæk(University of Copenhagen), John S. Babcook(Centre for Drug Research and Development), Ladan Fazli, Peter Johannes Holst(University of Copenhagen), Morten A. Nielsen(University of Copenhagen), Francesco Favero(Technical University of Denmark), Chris Kedong Wang, Makoto Endo(Kyushu University), Nader Al-Nakouzi(University of British Columbia), Joseph Zaia(Boston University), Htoo Zarni Oo(University of British Columbia), Yang Mao(Sun Yat-sen University), Robert Dagil(University of Copenhagen), Line Barington(University of Copenhagen), Thor G. Theander(University of Copenhagen), Le Meng(Boston University), Torsten O. Nielsen(BC Cancer Agency), Jo Soden, Madeleine Dahlbäck(University of Copenhagen), Jamie R. Rich(Centre for Drug Research and Development), Susan Thrane(University of Copenhagen), Jim Freeth, Glen J. Weiss(Translational Genomics Research Institute), Bradley J. Hedberg(Centre for Drug Research and Development), Poul H. Sorensen(BC Cancer Agency), Tobias Gustavsson(University of Copenhagen), Thomas Mandel Clausen(University of Copenhagen), Adam F. Sander(University of Copenhagen), Marina Ayres Pereira(University of Copenhagen), Sherry Lee, Janine LoBello(Translational Genomics Research Institute), Jeff Trent(Translational Genomics Research Institute), Nhan L. Tran(Mayo Clinic in Arizona)
Cited by 219
Related Papers
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
|Clinical Cancer Research|2008|1.2k